<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Transfusion Medicine Guidelines</title>
    <link href="https://fonts.googleapis.com/css2?family=Inter:wght@400;500;600;700&display=swap" rel="stylesheet">
    <link rel="stylesheet" href="../styles/main.css">
    <!-- Include MathJax -->
    <script>
    MathJax = {
        tex: {
            inlineMath: [['$', '$'], ['\\(', '\\)']],
            displayMath: [['$$', '$$'], ['\\[', '\\]']],
            processEscapes: true,
            processEnvironments: true,
            tags: 'ams' // Use AMS numbering of equations
        },
        svg: { fontCache: 'global' },
        options: {
            skipHtmlTags: ['script', 'noscript', 'style', 'textarea', 'pre']
        }
    };
    </script>
    <script src="https://polyfill.io/v3/polyfill.min.js?features=es6"></script>
    <script id="MathJax-script" async src="https://cdn.jsdelivr.net/npm/mathjax@3/es5/tex-mml-chtml.js"></script>
</head>
<body>
    <div class="container">
        <article class="document-section" role="main">
            <!-- Top Navigation -->
            <nav class="document-nav" role="navigation" aria-label="Document Sections">
                <div class="nav-links">
                    <a href="../index.html" class="nav-button">
                        <span class="nav-icon"></span>
                        <span class="nav-text">Table of Contents</span>
                    </a>
                    <a href="histology-blood-transfusion-clinical-applications.html" class="nav-button">
                        <span class="nav-icon">←</span>
                        <span class="nav-text">Previous Section</span>
                    </a>
                    <div class="document-progress">
                         <div class="progress-bar" aria-hidden="true">
                            <div class="progress-fill" style="width: 100%;"></div>
                        </div>
                       <span class="progress-text">Lecture 3 of 3</span>
                    </div>
                    <a href="#" class="nav-button disabled">
                        <span class="nav-text">Next Section</span>
                        <span class="nav-icon">→</span>
                    </a>
                </div>
            </nav>

            <header class="section-header">
                <h1 class="section-title">Transfusion Medicine Guidelines</h1>
                <p>Dr. Kibaru</p>
                <div class="title-underline"></div>
            </header>

            <main class="section-content">
                
                <!-- START: pediatric-guidelines -->
                <section id="pediatric-guidelines" class="content-section" aria-labelledby="section-heading-1">
                    <h2 id="section-heading-1" class="section-heading">
                         <span class="heading-icon"> </span>
                        <span class="heading-text">Indications for Transfusion in Children</span>
                    </h2>
                    <div class="content-card">
                        <p>In severe anaemia, give blood transfusion to:</p>
                        <ol type="A">
                            <li>All children with a haematocrit of less than 12% or Hb of less than $4 \mathrm{gm} / \mathrm{dl}$.</li>
                        </ol>
                        <aside class="callout note" role="note">
                            <p>Source: Pocket book of hospital care for children, guidelines for management of common illnesses with limited resources, WHO.</p>
                        </aside>
                        <ol type="A" start="2">
                            <li>Less severely anaemic children (haematocrit of $13\%-18\%$ or Hb $4-6 \mathrm{gm} / \mathrm{dl}$) with any of the following clinical features:
                                <ul>
                                    <li>Clinically detectable dehydration</li>
                                    <li>Impaired level of consciousness</li>
                                    <li>Heart failure</li>
                                    <li>Deep and laboured breathing</li>
                                    <li>Very high parasitaemia (more than 10% of red cells with parasites)</li>
                                </ul>
                            </li>
                            <li>Children with acute loss when $20-30\%$ of total volume has been lost or bleeding is continuing.</li>
                            <li>Children in septic shock.</li>
                            <li>To provide plasma and platelets for clotting factors.</li>
                            <li>For exchange transfusion in neonates.</li>
                        </ol>
                    </div>
                </section>
                <!-- END: pediatric-guidelines -->

                <!-- START: rbc-transfusion -->
                <section id="rbc-transfusion" class="content-section" aria-labelledby="section-heading-2">
                    <h2 id="section-heading-2" class="section-heading">
                         <span class="heading-icon"> </span>
                        <span class="heading-text">Red Blood Cell Transfusion</span>
                    </h2>
                    <div class="content-card">
                        <ul>
                            <li>Red blood cells (RBCs) are transfused to increase the oxygen-carrying capacity of the blood and, in turn, to maintain satisfactory tissue oxygenation.</li>
                            <li>If the estimated blood loss is &gt;25% of the circulating blood volume (&gt;17 mL/kg) and the patient's condition remains unstable, RBC transfusions may be indicated.</li>
                        </ul>
                        <p>In acutely ill children with severe pulmonary disease requiring assisted ventilation, it is common practice to maintain the hemoglobin level close to the normal range.</p>
                        <p>With chronic anemia, the decision to transfuse RBCs should not be based solely on blood hemoglobin levels because children compensate well and may be asymptomatic despite low hemoglobin levels.</p>
                        <p>Patients with iron-deficiency anemia are often treated successfully with oral iron alone, even at hemoglobin levels of &lt;5 g/dL.</p>
                        <p>Factors other than hemoglobin concentration to be considered in the decision to transfuse RBCs include:</p>
                        <ul>
                            <li>The patient's symptoms, signs, and functional capacities.</li>
                            <li>The presence of cardiorespiratory, vascular, and central nervous system disease.</li>
                            <li>The cause and anticipated course of the anemia.</li>
                            <li>Alternative therapies are not available.</li>
                        </ul>
                        <h3 class="subsection-heading">In Chronic Anaemia</h3>
                        <ul>
                            <li>It is important to balance the detrimental effects of anemia on growth and development vs the potential toxicity associated with repeated transfusions.</li>
                        </ul>
                    </div>
                    <div class="content-card">
                        <h3 class="subsection-heading">RBC Transfusion in Neonates</h3>
                        <ul>
                            <li>All neonates experience a decline in circulating RBC mass caused both by physiologic factors and, in sick premature infants, by phlebotomy blood losses.</li>
                            <li>In healthy term infants, the nadir hemoglobin value rarely falls to &lt;11 g/dL at an age of 10-12 wk. This "physiologic" drop in RBCs does not require transfusions.</li>
                            <li>The decline occurs earlier and is more pronounced in premature infants. The mean hemoglobin concentration falls to approximately 8 g/dL in infants of 1.0-1.5 kg birthweight and to 7 g/dL in infants weighing &lt;1.0 kg at birth. Most infants with birthweight of &lt;1.0 kg need RBC transfusions.</li>
                            <li>Nadir hemoglobin values of premature infants are lower because of a relatively diminished plasma EPO level in response to anemia.</li>
                        </ul>
                        <h4 class="subsubsection-heading">The mechanisms responsible for low plasma EPO levels are:</h4>
                        <ul>
                            <li>The reliance of preterm infants on the liver as the primary site of EPO production during the first few weeks of life. The liver is less responsive than the kidneys to anemia and tissue hypoxia.</li>
                        </ul>
                        <p>Preterm infants exhibit a sluggish EPO response to falling hematocrit values. Low plasma EPO levels provide a rationale for the use of recombinant EPO in the treatment of anemia of prematurity. Proper doses of EPO and iron effectively stimulate neonatal erythropoiesis.</p>
                        <ul>
                            <li>Stable neonates do not require RBC transfusion, regardless of their blood hemoglobin level, unless they exhibit clinical problems attributable to anemia.</li>
                        </ul>
                        <h4 class="subsubsection-heading">The RBC product of choice</h4>
                        <p>is the standard suspension of RBCs separated from whole blood by centrifugation and resuspended in an anticoagulant/preservative storage solution at a hematocrit value of approximately 60%.</p>
                        <ul>
                            <li>The usual dose is 10-15 mL/kg.</li>
                            <li><strong>N.B.</strong> Transfusion volumes vary greatly, depending on clinical circumstances (continued vs arrested bleeding, hemolysis).</li>
                        </ul>
                        <p>For neonates, a packed RBC concentrate (hematocrit of 70-90%) is preferred.</p>
                        <p>Either is infused slowly (over 2-4 hr) at a dose of approximately 15 mL/kg.</p>
                        <p>Because of the small quantity of extracellular fluid given at these relatively high hematocrit values and the slow rate of transfusion, the type of RBC anticoagulant/preservative solution used does not pose risks for premature infants.</p>
                    </div>
                    <div class="content-card">
                        <h3 class="subsection-heading">Guidelines for Pediatric Red Blood Cell Transfusions</h3>
                        <h4 class="subsubsection-heading">Infants within the First 4 Months of Life</h4>
                        <ul>
                            <li>Hemoglobin of &lt;13.0 g/dL and severe pulmonary disease</li>
                            <li>Hemoglobin of &lt;10.0 g/dL and moderate pulmonary disease</li>
                            <li>Hemoglobin of &lt;13.0 g/dL and severe cardiac disease</li>
                            <li>Hemoglobin of &lt;10.0 g/dL and major surgery</li>
                            <li>Hemoglobin of &lt;8.0 g/dL and symptomatic anemia</li>
                        </ul>
                        <h4 class="subsubsection-heading">Children and Adolescents</h4>
                        <ul>
                            <li>Acute loss of &gt;25% of circulating blood volume</li>
                            <li>Hemoglobin of &lt;8.0 g/dL in the perioperative period</li>
                            <li>Hemoglobin of &lt;13.0 g/dL and severe cardiopulmonary disease</li>
                            <li>Hemoglobin of &lt;8.0 g/dL and symptomatic chronic anemia</li>
                            <li>Hemoglobin of &lt;8.0 g/dL and marrow failure</li>
                        </ul>
                    </div>
                </section>
                <!-- END: rbc-transfusion -->

                <!-- START: transfusion-procedure -->
                <section id="transfusion-procedure" class="content-section" aria-labelledby="section-heading-3">
                    <h2 id="section-heading-3" class="section-heading">
                         <span class="heading-icon"> </span>
                        <span class="heading-text">Transfusion Procedure</span>
                    </h2>
                    <div class="content-card">
                        <ul>
                            <li>In severe anaemia, if packed cells are available, give 10 mls/kg over 3-4 hours.</li>
                            <li>Packed cells are preferred over whole blood. If not available, give fresh whole blood at 20 mls/kg over 3-4 hours.</li>
                            <li>Check respiratory rate and pulse rate every 15 min. If a rise is noted, transfuse more slowly.</li>
                            <li>If evidence of fluid overload occurs, give frusemide 1-2 mg/kg.</li>
                            <li>If there is no increment of Hb after transfusion, transfuse again.</li>
                            <li>In a malnourished child, give packed cells 10 ml/kg or whole blood 10 ml/kg.</li>
                            <li><strong>N.B.</strong> Do not repeat transfusion in malnutrition.</li>
                        </ul>
                    </div>
                </section>
                <!-- END: transfusion-procedure -->

                <!-- START: platelet-transfusion -->
                <section id="platelet-transfusion" class="content-section" aria-labelledby="section-heading-4">
                    <h2 id="section-heading-4" class="section-heading">
                         <span class="heading-icon"> </span>
                        <span class="heading-text">Platelet Transfusion</span>
                    </h2>
                    <div class="content-card">
                        <ul>
                            <li>Guidelines for platelet (PLT) support for children and adolescents with quantitative and qualitative PLT disorders are similar to those for adults.</li>
                            <li>PLT transfusions should be given to patients with PLT counts of &lt;50 x 10<sup>9</sup>/L when they are bleeding or are scheduled for an invasive procedure.</li>
                            <li>Studies of patients with thrombocytopenia from bone marrow failure indicate that spontaneous bleeding increases markedly when PLT levels fall to &lt;20 x 10<sup>9</sup>/L, if serious complications (infection, organ failure, clotting abnormalities, or anemia) are present. In this setting, prophylactic PLT transfusions are given to maintain a PLT count of &gt;20 x 10<sup>9</sup>/L.</li>
                            <li>PLT transfusions may be given to maintain relatively high PLT counts in situations of DIC, sepsis, active bleeding, or need for an invasive procedure.</li>
                            <li>In qualitative PLT disorders, PLT transfusions are justified only if significant bleeding occurs. Because inherited PLT dysfunction is long-term and repeated transfusions may lead to alloimmunization and refractoriness, prophylactic PLT transfusions are rarely justified, unless an invasive procedure is planned.</li>
                        </ul>
                        <p>A bleeding time of &gt; twice the upper limit of laboratory normal or an abnormal result may be taken as diagnostic evidence of PLT dysfunction, but the bleeding time or any other laboratory test result is poorly predictive of hemorrhagic risk or the need to transfuse PLTs.</p>
                        <p>Alternative therapies, particularly desmopressin acetate, should be considered to avoid PLT transfusions. Antiplatelet medications (nonsteroidal anti-inflammatory drugs) should be avoided in these patients.</p>
                        <ul>
                            <li>In neonates, hemostasis is quantitatively and qualitatively different from that in older children.</li>
                        </ul>
                        <p>Approximately 25% of neonates treated in an ICU exhibit blood PLT counts of &lt;150 x 10<sup>9</sup>/L at some time during admission. Pathogenetic mechanisms include accelerated PLT destruction and diminished PLT production.</p>
                        <p>The goal of most PLT transfusions is to raise the PLT count to &gt;50 x 10<sup>9</sup>/L and to &gt;100 x 10<sup>9</sup>/L for neonates.</p>
                        <p><strong>Dose:</strong> 10 mL/kg</p>
                        <p>Transfused within 2 hours.</p>
                    </div>
                    <div class="content-card">
                        <h3 class="subsection-heading">Guidelines for Pediatric Platelet Transfusions</h3>
                        <h4 class="subsubsection-heading">Children and Adolescents</h4>
                        <ul>
                            <li>PLTs &lt; 50 x 10<sup>9</sup>/L and bleeding.</li>
                            <li>PLTs &lt; 50 x 10<sup>9</sup>/L and an invasive procedure.</li>
                            <li>PLTs &lt; 20 x 10<sup>9</sup>/L and marrow failure with hemorrhagic risk factors.</li>
                            <li>PLTs &lt; 10 x 10<sup>9</sup>/L and marrow failure without hemorrhagic risk factors.</li>
                            <li>PLTs at any count, but with PLT dysfunction plus bleeding or an invasive procedure.</li>
                        </ul>
                        <h4 class="subsubsection-heading">Infants within the First 4 Months of Life</h4>
                        <ul>
                            <li>PLTs &lt; 50 x 10<sup>9</sup>/L and an invasive procedure.</li>
                            <li>PLTs &lt; 20 x 10<sup>9</sup>/L and clinically stable.</li>
                            <li>PLTs &lt; 100 x 10<sup>9</sup>/L and clinically unstable.</li>
                            <li>PLTs at any count, but with PLT dysfunction plus bleeding or an invasive procedure.</li>
                        </ul>
                    </div>
                </section>
                <!-- END: platelet-transfusion -->

                <!-- START: ffp-transfusion -->
                <section id="ffp-transfusion" class="content-section" aria-labelledby="section-heading-5">
                    <h2 id="section-heading-5" class="section-heading">
                         <span class="heading-icon"> </span>
                        <span class="heading-text">Fresh Frozen Plasma Transfusions</span>
                    </h2>
                    <div class="content-card">
                        <ul>
                            <li>FFP is transfused to replace clinically significant deficiencies of plasma proteins for which more highly purified concentrates are not available.</li>
                            <li>Requirements for FFP vary with the specific factor being replaced, but a starting dose is 15 mL/kg.</li>
                            <li>Indications include treatment of deficiencies of clotting factors II, V, X, and XI.</li>
                            <li>Deficiencies of factor XIII and fibrinogen are treated with cryoprecipitate.</li>
                        </ul>
                        <ul>
                            <li>Transfusion of FFP is not recommended for the treatment of patients with severe hemophilia A or B or for factor VII deficiency because safer factor VII, VIII, and IX concentrates are available.</li>
                            <li>FFP is used for rapid reversal of the effects of warfarin.</li>
                        </ul>
                        <p>Transfusion of FFP in patients with chronic liver disease and prolonged clotting times is not recommended unless bleeding is present or an invasive procedure is planned because correction of the clotting factor deficiencies is brief.</p>
                    </div>
                    <div class="content-card">
                        <h3 class="subsection-heading">Guidelines for Pediatric Fresh Frozen Plasma Transfusions</h3>
                        <h4 class="subsubsection-heading">Infants, Children, and Adolescents</h4>
                        <ul>
                            <li>Emergency reversal of warfarin effects.</li>
                            <li>Dilutional coagulopathy and bleeding.</li>
                            <li>Anticoagulant protein (antithrombin III, proteins C and S) replacement.</li>
                            <li>Plasma exchange replacement fluid for thrombotic thrombocytopenic purpura.</li>
                        </ul>
                    </div>
                </section>
                <!-- END: ffp-transfusion -->

                <!-- START: transfusion-reaction -->
                <section id="transfusion-reaction" class="content-section" aria-labelledby="section-heading-6">
                    <h2 id="section-heading-6" class="section-heading">
                         <span class="heading-icon"> </span>
                        <span class="heading-text">Transfusion Reaction</span>
                    </h2>
                    <div class="content-card">
                        <h3 class="subsection-heading">Mild Reaction (Mild Hypersensitivity)</h3>
                        <ul>
                            <li><strong>Symptom:</strong> Itchy rash.</li>
                            <li><strong>Management:</strong>
                                <ol>
                                    <li>Slow the transfusion.</li>
                                    <li>Give chlorpheniramine 0.1 mg IM.</li>
                                    <li>Continue transfusion at a normal rate if there is no progression of symptoms after 30 min.</li>
                                    <li>If symptoms persist, treat as a moderate reaction.</li>
                                </ol>
                            </li>
                        </ul>
                    </div>
                    <div class="content-card">
                        <h3 class="subsection-heading">Moderately Severe Reaction</h3>
                        <p>Due to moderate hypersensitivity, non-haemolytic reaction, pyrogens, or bacterial contamination.</p>
                        <h4 class="subsubsection-heading">Signs & Symptoms:</h4>
                        <ul>
                            <li>Severe rash, flushing, fever above 38°C.</li>
                            <li>Rigors, restlessness, raised heart rate.</li>
                        </ul>
                        <h4 class="subsubsection-heading">Treatment:</h4>
                        <ol>
                            <li>Stop the transfusion but keep the line patent with N/S.</li>
                            <li>Give IV hydrocortisone 200 mg or chlorpheniramine 0.25 mg/kg.</li>
                            <li>Give a bronchodilator if wheezing is present.</li>
                            <li>Send the following to the lab:
                                <ul>
                                    <li>The blood giving set that was used.</li>
                                    <li>A blood sample from another site.</li>
                                    <li>A urine sample collected over 24 hours.</li>
                                </ul>
                            </li>
                            <li>If there is improvement, restart the transfusion slowly with new blood and observe carefully.</li>
                            <li>If there is no improvement in 15 minutes, treat as life-threatening. Report to the doctor in charge and the blood bank.</li>
                        </ol>
                    </div>
                    <div class="content-card">
                        <h3 class="subsection-heading">Life-Threatening Reactions</h3>
                        <p>Due to haemolysis, bacterial contamination, septic shock, fluid overload, or anaphylaxis.</p>
                        <h4 class="subsubsection-heading">Signs & Symptoms:</h4>
                        <ul>
                            <li>Fever above 38°C, rigors, restlessness, raised heart rate, fast breathing, dark or red urine, unexplained bleeding, collapse.</li>
                        </ul>
                        <h4 class="subsubsection-heading">Treatment:</h4>
                        <ol>
                            <li>Stop the transfusion but keep the line patent.</li>
                            <li>Maintain airway and give oxygen.</li>
                            <li>Give Adrenaline 0.01 mg/kg body weight (0.1 ml of 1 in 10,000).</li>
                            <li>Treat shock.</li>
                            <li>Give IV hydrocortisone 200 mg or chlorpheniramine 0.1 mg/kg.</li>
                            <li>Give a bronchodilator if wheezing is present.</li>
                            <li>Report the reaction.</li>
                            <li>Maintain renal flow with IV Lasix 1 mg/kg.</li>
                            <li>Give antibiotics as for septicaemia.</li>
                        </ol>
                    </div>
                </section>
                <!-- END: transfusion-reaction -->

            </main>

            <!-- Bottom Navigation -->
             <nav class="document-nav" role="navigation" aria-label="Document Sections">
                <div class="nav-links">
                    <a href="../index.html" class="nav-button">
                        <span class="nav-icon"></span>
                        <span class="nav-text">Table of Contents</span>
                    </a>
                    <a href="histology-blood-transfusion-clinical-applications.html" class="nav-button">
                        <span class="nav-icon">←</span>
                        <span class="nav-text">Previous Section</span>
                    </a>
                    <div class="document-progress">
                         <div class="progress-bar" aria-hidden="true">
                            <div class="progress-fill" style="width: 100%;"></div>
                        </div>
                       <span class="progress-text">Lecture 3 of 3</span>
                    </div>
                    <a href="#" class="nav-button disabled">
                        <span class="nav-text">Next Section</span>
                        <span class="nav-icon">→</span>
                    </a>
                </div>
            </nav>

        </article>
    </div>
    <script src="../js/navigation.js"></script>
</body>
</html>